Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Ciclesonide Nasal Aerosol on HPA Axis in Children with PAR
NCT01378429Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Jul 2011
- Primary completion
- Nov 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ciclesonide in perennial allergic rhinitis (PAR), sponsored by Sumitomo Pharma America. Started Jul 2011; status: completed.
02
Drugs
ciclesonide
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT01378429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01378429.